{"id":"bibp-rec-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a recombinant vaccine, BIBP-Rec-Vaccine uses engineered protein antigens to trigger both humoral and cellular immune responses. The vaccine is intended to provide protective immunity by priming the adaptive immune system to recognize and respond to the target pathogen or disease antigen.","oneSentence":"BIBP-Rec-Vaccine is a recombinant protein-based vaccine designed to stimulate immune responses against specific disease targets.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:04:18.074Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05599516","phase":"PHASE3","title":"Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial","status":"UNKNOWN","sponsor":"National Vaccine and Serum Institute, China","startDate":"2022-11-04","conditions":"COVID-19, Coronavirus Infections","enrollment":16000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"BIBP-Rec-Vaccine","genericName":"BIBP-Rec-Vaccine","companyName":"National Vaccine and Serum Institute, China","companyId":"national-vaccine-and-serum-institute-china","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}